Round 2, 2022
- Hybrid genome assembly and annotation of Plasmodium vivax from the Asia-Pacific region
Paolo Bareng, Deakin University
- Determining the degree of infant exposure to primaquine through colostrum and transitional breast milk – opening the gateway to early postpartum radical cure to curb maternal Plasmodium vivax relapse
Dr Brioni Moore, Curtin University
- Predicting malaria transmissibility in a near elimination setting and identifying key drivers for malaria elimination
Dr Kinley Wangdi, Australian National University
- Genomic surveillance for emerging Plasmodium knowlesi malaria
Dr Jacob Westaway, Menzies School of Health Research
Round 1, 2022
- Defining the antigenic diversity of Plasmodium vivax apical membrane antigen-1 to inform vaccine development
Dr Lee Yeoh, Burnet Institute
- A statistical framework for identifying sufficient data to infer a total parasite biomass
Dr David Price, Doherty Institute, University of Melbourne
- Feasibility assessment of the use of Optical Mark Recognition around Vivax Malaria surveillance
Dr Mary Malai, Papua New Guinea Institute of Medical Research
- Utilising community malaria volunteers to expand molecular and serological surveillance of malaria in pre-elimination settings
Dr Win Han Oo, Burnet Institute
- Web-based interactive tool to improve decision-making for malaria elimination in Vietnam
Dr Yalemzewod Gelaw, Curtin University and Telethon Kids Institute
- Collection of cells to isolate monoclonal antibodies to placental malaria antigens
Dr Elizabeth Aitken, Doherty Institute, University of Melbourne
Round 2, 2021
- MinION sequencing for rapid detection of imported P. vivax cases
Dr Marianna Kleinecke, Menzies School of Health Research
- Estimating disease prevalence in a sentinel site catchment population to complement case-based suveillance and develop decision-making tools
Dr Diana Timbi, Papua New Guinea Institute of Medical Research
- Characterizing the longitudinal immune response to salivary antigens of Southeast Asian mosquito vectors of malaria, with a human challenge model
Ms Ellen Kearney, Burnet Institute, Melbourne School of Population and Global Health
- Understanding cross-reactive antibodies in children without documented exposure to malaria
Dr Rhea Longley, Walter and Eliza Hall Institute of Medical Research
- Artificial Intelligence-based drug resistance screening of malaria parasites using ‘Read Until’
Dr Kirsty McCann, Deakin University
- Methodological comparison of P. vivax genotyping approaches for molecular surveillance within the ACREME network
Dr Caitlin Bourke, Walter and Eliza Hall Institute of Medical Research
- Indentification of antibody targets and mechanisms associated with duration and spontaneous clearance of subclinical Plasmodium vivax infection
Dr Katherine O’Flaherty, Burnet Institute
Round 1, 2021
- Spatial imaging and transcriptomic analysis of immune cells and malaria parasites in Plasmodium-infected human spleens
Dr Steven Kho, Menzies School of Health Research
- Assessing the early development of functional antibody responses and target antigens in controlled human malaria infection to inform vaccine development
Dr Linda Reiling, Burnet Institute
- Investigating asymptomatic transmission of malaria parasites in the Madang province of Papua New Guinea
Dr Lincoln Timinao, Papua New Guinea Institute of Medical Research and Burnet Institute
Round 1, 2020
- Validating molecular and serological tools for detecting hidden reservoirs of Plasmodium infections in Papua New Guinea
Dr Fiona Angrisano, Burnet Institute
- Investigating antibody responses to mosquito salivary antigens across the Asia Pacific to advance novel malaria surveillance strategies
Dr Julia Cutts, Burnet Institute
- Understanding the role of polymorphisms in vaccine escape to guide malaria vaccine development and implementation
Dr Liriye Kurtovic, Burnet Institute
- Optimal geospatial design of malaria surveillance programs
Dr Freya Shearer, University of Melbourne
- Serological exposure markers for P. vivax in pregnant women
Dr Holger Unger, Menzies School of Health Research
- Characterizing antibody responses to PfEMP1 as biomarkers of severe and uncomplicated malaria in Papua New Guinea
Dr Isobel Walker, University of Melbourne
Round 2, 2019
- How best can we detect the hidden splenic parasite biomass in human Plasmodium infection? Part 1: peripheral blood
Dr Steven Kho, Menzies School of Health Research
- Age-dependent diversity of innate immune responses in malaria
Dr Jessica Loughland, QIMR Berghofer Medical Research Institute
- Use of proteomics as a platform for evaluating new biomarkers for improving diagnosis of Plasmodium vivax for the purpose of malaria elimination
Dr Sumudu Britton, QIMR Berghofer Medical Research Institute
- Investigating the transmissibility of artemisinin-resistant P. falciparum and the effect of artesunate on gametocyte production
Dr Zuleima Pava, QIMR Berghofer Medical Research Institute
Round 1, 2019
- Field evaluation of a Point-of-Contact device for P. falciparum malaria serosurveillance
Dr Aung Pyae Phyo, Burnet Institute
- Functional human antibodies that target P. falciparum gametocytes to reduce malaria transmission
Dr Jo-Anne Chan, Burnet Institute
- The impact of a malaria infection on G6PD activity (MAGY)
Dr Benedikt Ley, Menzies School of Health Research
- Building capacity for an innovative amplicon deep sequencing tool to genotype Plasmodium infections for improved surveillance
Dr Shazia Ruybal Pesántez, Walter and Eliza Hall Institute of Medical Research
- Development of a high-sensitivity reader for improving use of malaria RDTs
Dr Leanna Surrao, Burnet Institute
Round 2, 2018
- Enhanced geospatial surveillance for identifying malaria transmission hotspots using antenatal screening in PNG
Dr Ricardo Ataide, Burnet Institute
- Development of a novel mouse model of artemisinin-resistant malaria to screen and prioritize antimalarial drugs effective against artemisinin-resistant parasites
Dr Maria Rebelo, QIMR Berghofer Medical Research Institute
- Paving the way for universal radical cure
Dr Kamala Thriemer, Menzies School of Health Research
Round 1, 2018
- The cost-effectiveness of molecular epidemiology to inform malaria control program decision-making: a scoping exercise.
Dr Angela Devine, Burnet Institute
- Understanding RTS,S immunity to inform vaccine implementation and design an improved pre-erythrocyte stage vaccine to facilitate malaria elimination
Dr Gaoqian Feng, Burnet Institute
- Novel serological markers for surveillance of both P. vivax malaria exposure and immunity
Dr Rhea Longley, Walter and Eliza Hall Institute of Medical Research
- Developing a multiscale model combining both within-host and population level information to predict the emergence and spread of antimalarial resistance
Dr Pengxing Cao, University of Melbourne